The role of NIIMBL to advance manufacturing for Cell and Gene Therapy treatments

Conference Dates

February 6 – 10, 2022


The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.

Funding of $70 million has been committed by NIST for the next 5 years of NIIMBL and this is expected to be more than matched by participants. A key focus will be advancing manufacturing of Gene Therapy and Cell Therapy based products. Discussion is invited regarding the best role for this public-private partnership.

Poster 4.pdf (27 kB)

This document is currently not available here.